Valeant Pharmaceuticals Intl (NYSE:VRX)’s revenue slipped in the fourth quarter amid dropping drug prices March 1, 2017August 24, 2017 The Canadian drug giant Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) announced results of its fiscal fourth quarter as its revenue plunged…